aegerion pharmaceuticals aegr - crwenewswire stock to watch

Yüklenme Tarihi: 08 Ocak 2012 - 21:05

aegerion pharmaceuticals ıncorporated - aegr - provided a clinical update on its lomitapide. aegerion reported that the 78-week data from its pivotal phase ııı clinical trial is consistent with data previously reported at the 26- and 56-week time points.

Etiketler: aegerion, aegerion pharmaceuticals, aegr, nasdaqaegr